Maintaining and improving quality of life (QOL) and extending a healthy lifespan are among the most important objectives for an aging society. A research group led by Dr. Keiko Odera and Dr. Ryoya Takahashi, a former professor, from the Department of Biochemistry, Faculty of Pharmaceutical Sciences, has revealed that lifelong supplementation with PQQ and its derivative IPQ in senescence-accelerated mouse (SAM) P8 mice reduces mortality risk during midlife and delays the progression of aging and age-related decline in muscular function.
This article was originally published on MedicalXpress.com
